{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:52:54Z","timestamp":1791726774178,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebral Cavernous Malformations (CCMs) are vascular malformations of the central nervous system which can lead to moderate to severe neurological phenotypes in patients. A majority of CCM lesions are driven by a cancer-like three-hit mutational mechanism, including a somatic, activating mutation in the oncogene\n                    <jats:italic>PIK3CA<\/jats:italic>\n                    , as well as biallelic loss-of-function mutations in a CCM gene. However, standard sequencing approaches often fail to yield a full complement of pathogenic mutations in many CCMs. We suggest this reality reflects the limited sensitivity to identify low-frequency variants and the presence of mutations undetectable with bulk short-read sequencing. Here we report a single-nucleus DNA-sequencing approach that leverages the underlying biology of CCMs to identify lesions with somatic loss-of-heterozygosity, a class of such hidden mutations. We identify an alternative genetic mechanism for CCM pathogenesis and establish a method that can be repurposed to investigate the genetic underpinning of other disorders with multiple somatic mutations.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-42908-w","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T07:02:06Z","timestamp":1698908526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-2774","authenticated-orcid":false,"given":"Andrew K.","family":"Ressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Snellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Gallione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Lightle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-6671","authenticated-orcid":false,"given":"Douglas A.","family":"Marchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"42908_CR1","doi-asserted-by":"publisher","first-page":"rt1","DOI":"10.1091\/mbc.E21-08-0407","volume":"32","author":"J Chernoff","year":"2021","unstructured":"Chernoff, J. The two-hit theory hits 50. Mol. Biol. Cell 32, rt1 (2021).","journal-title":"Mol. Biol. Cell"},{"key":"42908_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820\u2013823 (1971).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"42908_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M. & Marchuk, D. A. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet. 18, 919\u2013930 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"42908_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings, D. A. et al. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in bi-allelic loss of ENG or ACVRL1. Am. J. Hum. Genet. 105, 894\u2013906 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"42908_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1086\/339492","volume":"70","author":"P Brouillard","year":"2002","unstructured":"Brouillard, P. et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (\u201cGlomangiomas\u201d). Am. J. Hum. Genet. 70, 866\u2013874 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"42908_CR6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/humu.22431","volume":"34","author":"N Revencu","year":"2013","unstructured":"Revencu, N. et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation\u2013arteriovenous malformation. Hum. Mutat. 34, 1632\u20131641 (2013).","journal-title":"Hum. Mutat."},{"key":"42908_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1227\/01.NEU.0000348049.81121.C1","volume":"65","author":"J Gault","year":"2009","unstructured":"Gault, J. et al. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 65, 138\u2013145 (2009).","journal-title":"Neurosurgery"},{"key":"42908_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.38.2.81","volume":"38","author":"IPM Tomlinson","year":"2001","unstructured":"Tomlinson, I. P. M., Roylance, R. & Houlston, R. S. Two hits revisited again. J. Med. Genet. 38, 81\u201385 (2001).","journal-title":"J. Med. Genet."},{"key":"42908_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0714-y","volume":"12","author":"JJ Adashek","year":"2020","unstructured":"Adashek, J. J., Kato, S., Lippman, S. M. & Kurzrock, R. The paradox of cancer genes in non-malignant conditions: implications for precision medicine. Genome Med. 12, 16 (2020).","journal-title":"Genome Med."},{"key":"42908_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/B978-0-444-63640-9.00027-8","volume":"143","author":"JA Ellis","year":"2017","unstructured":"Ellis, J. A. & Barrow, D. L. Supratentorial cavernous malformations. Handb. Clin. Neurol. 143, 283\u2013289 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"42908_CR11","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1227\/01.NEU.0000249188.38409.03","volume":"59","author":"J Gault","year":"2006","unstructured":"Gault, J., Sain, S., Hu, L.-J. & Awad, I. A. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery 59, 1278\u20131284 (2006).","journal-title":"Neurosurgery"},{"key":"42908_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","volume":"74","author":"KD Flemming","year":"2017","unstructured":"Flemming, K. D. et al. Population-based prevalence of cerebral cavernous malformations in older adults: mayo clinic study of aging. JAMA Neurol. 74, 801\u2013805 (2017).","journal-title":"JAMA Neurol."},{"key":"42908_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5604\/01.3001.0012.8316","volume":"8","author":"I Czekalska","year":"2018","unstructured":"Czekalska, I., Tyrakowska-Dade\u0142\u0142o, Z., Werel, P., Taras\u00f3w, E. & Grodzka, E. Cerebral cavernous malformations: epidemiological, clinical and diagnostic imaging aspects. Prog. Health Sci. 8, 8\u201317 (2018).","journal-title":"Prog. Health Sci."},{"key":"42908_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486292","volume":"9","author":"S Spiegler","year":"2018","unstructured":"Spiegler, S., Rath, M., Paperlein, C. & Felbor, U. Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol. Syndromol. 9, 60\u201369 (2018).","journal-title":"Mol. Syndromol."},{"key":"42908_CR15","unstructured":"Morrison, L. & Akers, A. Cerebral cavernous malformation, familial. In GeneReviews\u00ae (eds. Adam, M. P. et al.) (University of Washington, Seattle, 1993)."},{"key":"42908_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1161\/STROKEAHA.118.022314","volume":"50","author":"A Zafar","year":"2019","unstructured":"Zafar, A. et al. Familial cerebral cavernous malformations. Stroke 50, 1294\u20131301 (2019).","journal-title":"Stroke"},{"key":"42908_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","volume":"32","author":"Z Zhou","year":"2015","unstructured":"Zhou, Z. et al. The cerebral cavernous malformation pathway controls embryonic endocardial gene expression through regulation of MEKK3 signaling and KLF expression. Dev. Cell 32, 168\u2013180 (2015).","journal-title":"Dev. Cell"},{"key":"42908_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s44161-022-00035-7","volume":"1","author":"DA Snellings","year":"2022","unstructured":"Snellings, D. A. et al. Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat. Cardiovasc. Res. 1, 246\u2013252 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"42908_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren, A. A. et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594, 271\u2013276 (2021).","journal-title":"Nature"},{"key":"42908_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/hmg\/ddq433","volume":"20","author":"DA McDonald","year":"2011","unstructured":"McDonald, D. A. et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum. Mol. Genet. 20, 211\u2013222 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"42908_CR21","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday, G. et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208, 1835\u20131847 (2011).","journal-title":"J. Exp. Med."},{"key":"42908_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z. et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signaling. Nature 532, 122\u2013126 (2016).","journal-title":"Nature"},{"key":"42908_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S0002-9440(10)63409-8","volume":"165","author":"NW Plummer","year":"2004","unstructured":"Plummer, N. W. et al. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol. 165, 1509\u20131518 (2004).","journal-title":"Am. J. Pathol."},{"key":"42908_CR24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre, M. et al. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N. Engl. J. Med. 385, 996\u20131004 (2021).","journal-title":"N. Engl. J. Med."},{"key":"42908_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/hmg\/ddn420","volume":"18","author":"A Pagenstecher","year":"2009","unstructured":"Pagenstecher, A., Stahl, S., Sure, U. & Felbor, U. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum. Mol. Genet. 18, 911\u2013918 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"42908_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","volume":"108","author":"J Weng","year":"2021","unstructured":"Weng, J. et al. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation. Am. J. Hum. Genet. 108, 942\u2013950 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"42908_CR27","doi-asserted-by":"publisher","first-page":"i211","DOI":"10.1093\/bioinformatics\/bty286","volume":"34","author":"G Satas","year":"2018","unstructured":"Satas, G. & Raphael, B. J. Haplotype phasing in single-cell DNA-sequencing data. Bioinformatics 34, i211\u2013i217 (2018).","journal-title":"Bioinformatics"},{"key":"42908_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"P-R Loh","year":"2018","unstructured":"Loh, P.-R. et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature 559, 350\u2013355 (2018).","journal-title":"Nature"},{"key":"42908_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","volume":"584","author":"P-R Loh","year":"2020","unstructured":"Loh, P.-R., Genovese, G. & McCarroll, S. A. Monogenic and polygenic inheritance become instruments for clonal selection. Nature 584, 136\u2013141 (2020).","journal-title":"Nature"},{"key":"42908_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41439-022-00211-y","volume":"9","author":"A Hattori","year":"2022","unstructured":"Hattori, A. et al. Maternal uniparental disomy of chromosome 7 underlying argininosuccinic aciduria and Silver-Russell syndrome. Hum. Genome Var. 9, 32 (2022).","journal-title":"Hum. Genome Var."},{"key":"42908_CR31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/ccr3.1061","volume":"5","author":"LC Gerbrands","year":"2017","unstructured":"Gerbrands, L. C., Haarman, E. G., Hankel, M. A. & Finken, M. J. J. Cystic fibrosis and Silver-Russell syndrome due to a partial maternal isodisomy of chromosome 7. Clin. Case Rep. 5, 1697\u20131700 (2017).","journal-title":"Clin. Case Rep."},{"key":"42908_CR32","unstructured":"Olson, T. S., et al.) Monosomy 7 predisposition syndromes overview. In GeneReviews\u00ae (eds. Adam, M. P. et al.) (University of Washington, Seattle, 1993)."},{"key":"42908_CR33","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1182\/blood-2011-12-397620","volume":"119","author":"A Jerez","year":"2012","unstructured":"Jerez, A. et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119, 6109\u20136117 (2012).","journal-title":"Blood"},{"key":"42908_CR34","doi-asserted-by":"crossref","unstructured":"Martelotto L. G. \u2018Frankenstein\u2019 protocol for nuclei isolation from fresh and frozen tissue for snRNAseq (protocols.io, 2020).","DOI":"10.17504\/protocols.io.bqxymxpw"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42908-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T07:03:10Z","timestamp":1698908590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42908-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42908"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-42908-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.A. is a consultant for Neurelis, Inc. The remaining authors have declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7009"}}